NorthWest Biotherapeutics Inc (NWBO)

[CogDiss 1188X]

CLSN from $9500 to $1 a share

This doesn’t pass the smell test. If this chart were correct, then Celsion would have been worth $317 billion back in the day., more than 50% bigger than Merck now.

I suspect this is one of those bad data situations after multiple reverse splits.

In any case, Biosect’s point was that OTC stocks are subject to manipulation and in any case, the market is not efficient.

Your two examples are NASDAQ stocks. Is it your contention that microcap OTC stocks are free from manipulation or that microcap biotech OTC stocks are efficient in terms of information and price?